TAR-210 results show 90 percent recurrence-free survival and 90 percent complete response in patients with high-risk and intermediate-risk non-muscle-invasive bladder cancer, respectively
May 05, 2024 14:39 ET
|
Janssen Cilag International NV
Updated results reinforce the potential of TAR-210 to transform treatment of non-muscle-invasive bladder cancer with fibroblast growth factor receptor (FGFR) alterations1 BEERSE, BELGIUM, May 05,...
Studies Presented at AUA 2024 Highlight Latest Research on Voiding Dysfunction and BPH
May 04, 2024 13:48 ET
|
American Urological Association
SAN ANTONIO, May 04, 2024 (GLOBE NEWSWIRE) -- Abstracts being presented at the American Urological Association's Annual Meeting show the risk of benign prostatic hyperplasia (BPH) can be inherited...
Correction: Final Results
May 03, 2024 13:10 ET
|
Octopus Titan VCT plc
This announcement replaces the Final Results announcement released at 18:00 on 24 April 2024 which included an incorrect reference to the dividend being paid on 24 May 2024 to shareholders on the...
TAR-200 monotherapy shows greater than 80 percent complete response rate in patients with high-risk non-muscle-invasive bladder cancer
May 03, 2024 11:53 ET
|
Janssen Cilag International NV
New data from Phase 2b SunRISe-1 study show rapid achievement of complete response (CR) with 98 percent achieving a CR within 12 weeks1 TAR-200 provides durable CRs in patients with Bacillus...
BLUE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that bluebird bio, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
May 03, 2024 10:00 ET
|
Bronstein, Gewirtz & Grossman, LLC
NEW YORK, May 03, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been...
Cumulus Media Reports Operating Results for the First Quarter 2024; Refinances its Capital Structure to Secure Five-Year Maturities Through Successful Debt Exchange and ABL Facility Upsize and Extension
May 03, 2024 08:01 ET
|
Cumulus Media Inc.
Completed Successful Debt Exchange That Reduced Principal by Approximately $33 Million, Extended Maturities to 2029, Obtained Favorable Interest Rates and Preserved Structure Free of Financial...
Plains All American Reports First-Quarter 2024 Results
May 03, 2024 07:30 ET
|
Plains All American Pipeline, L.P.; Plains GP Holdings
Provides Update on Permian Long-Haul Contracting & Announces Bolt-on Acquisitions HOUSTON, May 03, 2024 (GLOBE NEWSWIRE) -- Plains All American Pipeline, L.P. (Nasdaq: PAA) and Plains GP...
Chart Industries Reports First Quarter 2024 Financial Results
May 03, 2024 06:30 ET
|
Chart Industries, Inc.
ATLANTA, May 03, 2024 (GLOBE NEWSWIRE) -- Chart Industries, Inc. (NYSE: GTLS) (“Chart”) today reported results for the first quarter ended March 31, 2024. Results shown are from continuing...
Physician Perspective on Generic Drugs Thematic Research Report 2024
May 03, 2024 06:07 ET
|
Research and Markets
Dublin, May 03, 2024 (GLOBE NEWSWIRE) -- The "Generic Drugs (Physician Perspective) - Thematic Research" report has been added to ResearchAndMarkets.com's offering. This report combines...
Global Graft Versus Host Disease (GVHD) Clinical Trials Review 2024
May 03, 2024 06:01 ET
|
Research and Markets
Dublin, May 03, 2024 (GLOBE NEWSWIRE) -- The "Graft Versus Host Disease (GVHD) - Global Clinical Trials Review, 2024" report has been added to ResearchAndMarkets.com's offering.This report will...